Minhang Xin
Affiliations: | 2017 | Georgia State University, Atlanta, GA, United States |
Google:
"Minhang Xin"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bai H, Yang Z, Lei H, et al. (2024) Discovery of novel pyrrolo[2,3-d]pyrimidines as potent menin-mixed lineage leukemia interaction inhibitors. European Journal of Medicinal Chemistry. 268: 116226 |
| Xi XX, Zhao HY, Mao YZ, et al. (2023) Modification of osimertinib to discover new potent EGFR-TK inhibitors. European Journal of Medicinal Chemistry. 261: 115865 |
| Bai H, Sun J, Lei H, et al. (2023) Discovery of novel pyrido[3,2-d]pyrimidine derivatives as selective and potent PI3Kδ inhibitors. Drug Development Research |
| Gao L, Chuai H, Ma M, et al. (2023) Design, synthesis and bioactivity evaluation of selenium-containing PI3Kδ inhibitors. Bioorganic Chemistry. 140: 106815 |
| Ma M, Feng Y, Zhang SQ, et al. (2023) Design, synthesis and biological evaluation of novel selective PI3Kδ inhibitors containing pyridopyrimidine scaffold. Future Medicinal Chemistry |
| Lei H, Duan W, Zhang SQ, et al. (2023) Discovery of potent and selective PI3Kδ inhibitors bearing amino acid fragments. Bioorganic Chemistry. 138: 106594 |
| Lei H, Zhang SQ, Bai H, et al. (2022) Discovery of Novel, Potent, and Selective Small-Molecule Menin-Mixed Lineage Leukemia Interaction Inhibitors through Attempting Introduction of Hydrophilic Groups. Journal of Medicinal Chemistry |
| Chuai H, Zhang SQ, Bai H, et al. (2021) Small molecule selenium-containing compounds: Recent development and therapeutic applications. European Journal of Medicinal Chemistry. 223: 113621 |
| Yang XY, Zhao HY, Lei H, et al. (2020) Synthesis and biological evaluation of 10-substituted camptothecin derivatives with improved water solubility and activity. Chemmedchem |
| Xin M, Sun J, Huang W, et al. (2020) Design and synthesis of novel phthalazinone derivatives as potent poly(ADP-ribose)polymerase 1 inhibitors. Future Medicinal Chemistry |